These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
466 related articles for article (PubMed ID: 12491509)
21. Evaluation of the surgical completeness after total thyroidectomy for differentiated thyroid carcinoma. Salvatori M; Raffaelli M; Castaldi P; Treglia G; Rufini V; Perotti G; Lombardi CP; Rubello D; Ardito G; Bellantone R Eur J Surg Oncol; 2007 Jun; 33(5):648-54. PubMed ID: 17433606 [TBL] [Abstract][Full Text] [Related]
22. [Thyroglobulin levels in needle lymph node cytology for the detection of papillary thyroid cancer recurrence]. Véliz J; Brantes S; Ramos C; Aguayo J; Cáceres E; Herrera M; Barber A; Barría M; Wohllk N Rev Med Chil; 2008 Sep; 136(9):1107-12. PubMed ID: 19030653 [TBL] [Abstract][Full Text] [Related]
23. Value of serum thyroglobulin measurement in patients operating on for well differentiated thyroid carcinoma. Rüter A; Smeds S; Lennquist S Eur J Surg; 1998 Sep; 164(9):665-71. PubMed ID: 9728785 [TBL] [Abstract][Full Text] [Related]
24. [Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma]. Zöphel K; Wunderlich G; Liepach U; Koch R; Bredow J; Franke WG Nuklearmedizin; 2001 Oct; 40(5):155-63. PubMed ID: 11727628 [TBL] [Abstract][Full Text] [Related]
25. [Diagnostic performance of serum thyroglobin and iodide-131 Na scan according to the type of recurrence in differentiated thyroid carcinoma]. Zafon C; Galofré P; Hernández C; Gemar E; Obiols B; Mesa J; Simó R Med Clin (Barc); 2000 Apr; 114(13):487-90. PubMed ID: 10846652 [TBL] [Abstract][Full Text] [Related]
27. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer. Lima N; Cavaliere H; Tomimori E; Knobel M; Medeiros-Neto G J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080 [TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas. Furlan JC; Bedard YC; Rosen IB J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733 [TBL] [Abstract][Full Text] [Related]
29. Surgery of thyroid cancer: twelve years' personal experience. Pareschi R; Mincione A; Destito D; Mola M; Righini S; Assi A; Dottorini M Acta Otorhinolaryngol Ital; 2004 Dec; 24(6):348-53. PubMed ID: 15952685 [TBL] [Abstract][Full Text] [Related]
30. The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies. Boi F; Baghino G; Atzeni F; Lai ML; Faa G; Mariotti S J Clin Endocrinol Metab; 2006 Apr; 91(4):1364-9. PubMed ID: 16434461 [TBL] [Abstract][Full Text] [Related]
31. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life. Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427 [TBL] [Abstract][Full Text] [Related]
32. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation]. Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893 [TBL] [Abstract][Full Text] [Related]
33. Thyroglobulin before ablation and correlation with posttreatment scanning. de Rosário PW; Guimarães VC; Maia FF; Fagundes TA; Purisch S; Padrao EL; Rezende LL; Barroso AL Laryngoscope; 2005 Feb; 115(2):264-7. PubMed ID: 15689747 [TBL] [Abstract][Full Text] [Related]
34. Thyroglobulin measurement vs iodine 131 total-body scan for follow-up of well-differentiated thyroid cancer. Aiello DP; Manni A Arch Intern Med; 1990 Feb; 150(2):437-9. PubMed ID: 2105703 [TBL] [Abstract][Full Text] [Related]
35. Diagnostic follow-up of well-differentiated thyroid carcinoma: historical perspective and current status. Schlumberger MJ J Endocrinol Invest; 1999; 22(11 Suppl):3-7. PubMed ID: 10726999 [TBL] [Abstract][Full Text] [Related]
36. Treatment of locally aggressive well-differentiated thyroid cancer. Martins AS; Melo GM; Valério JB; Langner E; Lage HT; Tincani AJ Int Surg; 2001; 86(4):213-9. PubMed ID: 12056464 [TBL] [Abstract][Full Text] [Related]
37. Hürthle cell carcinoma: a clinicopathological study of thirteen cases. Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925 [TBL] [Abstract][Full Text] [Related]
38. Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in high- and low-risk patients. Duren M; Siperstein AE; Shen W; Duh QY; Morita E; Clark OH Surgery; 1999 Jul; 126(1):13-9. PubMed ID: 10418587 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer. Milas M; Barbosa GF; Mitchell J; Berber E; Siperstein A; Gupta M Ann Surg Oncol; 2009 Feb; 16(2):473-80. PubMed ID: 19015922 [TBL] [Abstract][Full Text] [Related]
40. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution. Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]